Overview

Treatment of Apathy in Alzheimer's Disease With Modafinil

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
This study examined the effects of modafinil on apathetic symptomatology, performance of activities of daily living (ADLs) and caregiver burden in individuals with Alzheimer's disease (AD).
Phase:
Phase 3
Details
Lead Sponsor:
Brown University
Collaborators:
Cephalon
National Institute of Mental Health (NIMH)
Treatments:
Armodafinil
Modafinil